Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric E Gardner

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Molecular Cancer Therapeutics|March 22, 2013
ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancerRebekah L Zinn, Eric E Gardner, Luigi Marchionni, et al.
Cancer Research|March 12, 2014
Rapamycin rescues ABT-737 efficacy in small cell lung cancerEric E Gardner, Nick Connis, John T Poirier, et al.
Photochemistry and Photobiology|December 25, 2018
Structural and Functional Consequences of the Weak Binding of Chlorin e6 to Bovine RhodopsinJames Mitchell, Naveena Yanamala, Yi Lei Tan, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Propionate metabolism dysregulation promotes drug-tolerant persister cell survival in non-small cell lung cancerBobak Parang, Liron Yoffe, Rabia Khan, et al.
Scientific Reports|March 19, 2026
Propionate metabolism is dysregulated in non-small cell lung cancer patients and EGFR-mutant drug-tolerant persister cellsBobak Parang, Liron Yoffe, Rabia Khan, et al.
Science (New York, N.Y.)|February 8, 2024
Lineage-specific intolerance to oncogenic drivers restricts histological transformationEric E Gardner, Ethan M Earlie, Kate Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2020
Role of mTOR As an Essential Kinase in SCLCJeffrey A Kern, Jihye Kim, Daniel G Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2016
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung CancerBenjamin H Lok, Eric E Gardner, Valentina E Schneeberger, et al.
JTO Clinical and Research Reports|March 20, 2026
Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and StrategiesMontse Sanchez-Cespedes, William W Lockwood, Kenichi Suda, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
LKB1 suppresses growth and promotes the internalization of EGFR through the PIKFYVE lipid kinaseJohn R Ferrarone, Jerin Thomas, Arun M Unni, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|March 22, 2013
ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancerRebekah L Zinn, Eric E Gardner, Luigi Marchionni, et al.
Cancer Research|March 12, 2014
Rapamycin rescues ABT-737 efficacy in small cell lung cancerEric E Gardner, Nick Connis, John T Poirier, et al.
Photochemistry and Photobiology|December 25, 2018
Structural and Functional Consequences of the Weak Binding of Chlorin e6 to Bovine RhodopsinJames Mitchell, Naveena Yanamala, Yi Lei Tan, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Propionate metabolism dysregulation promotes drug-tolerant persister cell survival in non-small cell lung cancerBobak Parang, Liron Yoffe, Rabia Khan, et al.
Scientific Reports|March 19, 2026
Propionate metabolism is dysregulated in non-small cell lung cancer patients and EGFR-mutant drug-tolerant persister cellsBobak Parang, Liron Yoffe, Rabia Khan, et al.
Science (New York, N.Y.)|February 8, 2024
Lineage-specific intolerance to oncogenic drivers restricts histological transformationEric E Gardner, Ethan M Earlie, Kate Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2020
Role of mTOR As an Essential Kinase in SCLCJeffrey A Kern, Jihye Kim, Daniel G Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2016
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung CancerBenjamin H Lok, Eric E Gardner, Valentina E Schneeberger, et al.
JTO Clinical and Research Reports|March 20, 2026
Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and StrategiesMontse Sanchez-Cespedes, William W Lockwood, Kenichi Suda, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
LKB1 suppresses growth and promotes the internalization of EGFR through the PIKFYVE lipid kinaseJohn R Ferrarone, Jerin Thomas, Arun M Unni, et al.
Pageof 3